Lung Cancer Clinical Trial

Auris Robotic Endoscopy System for Bronchoscopy

Summary

In this study, the performance related to the use of the novel Robotic Endoscopy Platform during bronchoscopic procedures will be evaluated.

View Full Description

Full Description

The early and accurate diagnosis of lung cancer is critical. However, many peripheral lung lesions are beyond the reach of conventional bronchoscopes. Additionally, alternative techniques, such as CT-guided or surgical biopsy, can carry increased risks to the patient. Diagnostic yield of flexible bronchoscopy is limited by its inability to guide biopsy instruments directly to the lesion. Varying technologies have been proposed to guide endobronchial biopsies, such as electromagnetic navigation, endobronchial ultrasound (EBUS) and computed tomography fluoroscopy. However, the correlation of real-time guidance and the ability to precisely direct a biopsy instrument is critical to biopsy success.

In this study , the novel Robotic Endoscopy Platform and its accessories will be used to provide bronchoscopic visualization of and access to patient airways for diagnostic procedures. Commercially available biopsy instruments will be used to acquire tissue for diagnostic purposes.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

18 to 80 years of age;
Capable and willing to give informed consent;
Acceptable candidate for an elective, non-emergent bronchoscopic procedure;
Solid peripheral lung lesions suspected of malignancy, between 1.5-7cm in size identified on thin slice CT scan with 30 days of the intended bronchoscopy

Exclusion Criteria:

Medical contraindication to bronchoscopy;
Ground glass opacity lesions on pre-procedure CT
Participation in any other clinical trial 30 days before and throughout the duration of the study;
Uncontrolled or irreversible coagulopathy;
Female subjects who are pregnant or nursing or those of child-bearing potential refusing a pregnancy test;
CT scan done over a month before the bronchoscopy procedure.

Intra-Procedure Exclusion Criteria: Any presenting condition discovered intra-procedurally that in the opinion of the investigator would make participating in this study not in the patient's best interest.

Study is for people with:

Lung Cancer

Estimated Enrollment:

4

Study ID:

NCT03497026

Recruitment Status:

Terminated

Sponsor:

Auris Health, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

El Camino Hospital
Mountain View California, 94040, United States
Palo Alto Medical Foundation Mountain View Center
Mountain View California, 94040, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

4

Study ID:

NCT03497026

Recruitment Status:

Terminated

Sponsor:


Auris Health, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider